Home Health Tips WHO Issues First Type 1 Diabetes Guidelines for Adults: 7 Things Patients Need to Know
Health TipsInternational NewsLatest NewsLifestyle & WellnessWHO

WHO Issues First Type 1 Diabetes Guidelines for Adults: 7 Things Patients Need to Know

Share
WHO
Share

More than 100 years after the discovery of insulin, millions of people living with type 1 diabetes continue to face challenges in accessing affordable treatment and essential diabetes care. In a significant development, the World Health Organization (WHO) has issued its first-ever guidelines specifically addressing the diagnosis and management of type 1 diabetes in adults.

Announced on November 14, 2026, ahead of World Diabetes Day, the guidelines aim to improve access to safe, effective and affordable diabetes treatment across different healthcare settings, including low-resource countries, emergency situations and humanitarian crises.

According to WHO, approximately 9.5 million people were living with type 1 diabetes globally in 2025, with another 500,000 people diagnosed during the same year. While type 1 diabetes is often associated with childhood, it can develop at any age, including adulthood.

The new recommendations place particular emphasis on insulin treatment, regular blood glucose monitoring and ensuring that people living with the condition receive continuous medical support.

But what exactly has WHO recommended, and what do these guidelines mean for adults living with type 1 diabetes? Here are seven important things patients and caregivers should know.

WHO Issues First Type 1 Diabetes Guidelines For Adults: Why Does It Matter?

Type 1 diabetes is a chronic autoimmune condition in which the body’s immune system attacks the insulin-producing beta cells in the pancreas. As a result, the body produces little or no insulin, a hormone essential for regulating blood glucose levels.

Unlike type 2 diabetes, which is often associated with insulin resistance and may initially be managed through lifestyle changes and medication, type 1 diabetes requires lifelong insulin treatment.

WHO’s new guidelines, published on November 12, 2026, provide evidence-based recommendations for insulin use, treatment delivery, diagnosis, classification and glucose monitoring in adults.

The recommendations are particularly important for countries where access to insulin, glucose monitoring devices and specialist diabetes care remains limited.

WHO also aims to support its global target of ensuring that all people with type 1 diabetes have access to affordable insulin treatment and blood glucose self-monitoring by 2030.

7 Things Patients Need To Know About WHO’s New Type 1 Diabetes Guidelines

1. Multiple Daily Insulin Injections Remain Central To Treatment

One of the key recommendations is that adults with type 1 diabetes should receive intensified insulin therapy, generally involving multiple daily injections.

Since their bodies cannot produce sufficient insulin, patients need external insulin to regulate blood glucose levels and prevent potentially life-threatening complications.

WHO recommends adjusting insulin doses according to blood glucose readings.

The treatment approach generally involves:

  • Basal insulin: Provides background insulin throughout the day and night to regulate blood glucose between meals and during sleep.
  • Mealtime insulin: Helps manage the rise in blood glucose after eating.

Insulin treatment must be individualised according to a person’s glucose levels, dietary intake, activity and medical requirements.

2. Human Insulin Is An Effective And More Affordable Treatment Option

Another important aspect of WHO’s recommendations is the emphasis on affordable insulin.

The guidelines recognise both human insulin and insulin analogues as treatment options for adults with type 1 diabetes.

Human insulin is a manufactured form of insulin that works similarly to the hormone naturally produced by the body. It is generally less expensive and can be an appropriate and effective treatment option.

Insulin analogues are modified forms of insulin designed to have different absorption and activity profiles. They may be used when clinically needed.

WHO’s emphasis on human insulin is particularly relevant for low-resource settings, where the cost and availability of insulin can become major barriers to continuous treatment.

However, the choice of insulin should always be made with a healthcare professional. Patients should never switch insulin formulations or alter their doses without medical advice.

3. Regular Blood Glucose Monitoring Is Essential

WHO recommends regular monitoring of blood glucose levels to help patients and healthcare professionals assess how effectively diabetes is being managed.

Monitoring allows patients to understand fluctuations in blood glucose and make informed decisions about insulin doses, meals and daily activities.

The guidelines highlight different methods of glucose monitoring:

  • Finger-prick blood glucose testing: Uses a small blood sample to measure current glucose levels through a glucose meter.
  • Continuous glucose monitoring (CGM): Uses a small sensor worn on the skin to measure glucose levels throughout the day and night.
  • Clinic-based blood tests: HbA1c testing helps assess average blood glucose levels over approximately the previous two to three months.

WHO also recognises urine glucose testing as an option in settings where blood glucose testing is unavailable. However, it is not equivalent to blood glucose monitoring and provides less precise information.

4. Continuous Glucose Monitoring Can Help Patients Track Sugar Levels

Continuous glucose monitoring (CGM) is an important development in diabetes management because it allows patients to monitor glucose trends without relying exclusively on repeated finger-prick tests.

A CGM device uses a small sensor placed under the skin to measure glucose levels in the fluid surrounding body cells.

Depending on the device, it can provide:

  • Regular glucose readings throughout the day.
  • Information about rising or falling glucose levels.
  • Alerts for dangerously low or high glucose levels.
  • Glucose trend information that helps guide treatment decisions.

WHO’s newly released guidance recognises CGM as one of the options for home glucose monitoring.

Access and affordability remain important considerations, particularly in countries where these devices may not be readily available.

Patients who cannot access CGM can still manage their condition through appropriate blood glucose testing and regular medical supervision.

5. Type 1 Diabetes Care Must Continue During Emergencies And Humanitarian Crises

One of the important features of the new WHO guidelines is their applicability to emergency and humanitarian settings.

People living with type 1 diabetes cannot safely discontinue insulin treatment, even during natural disasters, conflicts, displacement or disruptions to healthcare services.

Interrupted insulin supplies and limited access to glucose monitoring can increase the risk of serious complications, including diabetic ketoacidosis (DKA).

The guidelines aim to help healthcare providers and policymakers develop practical approaches to ensure continuity of treatment, even when healthcare infrastructure and medical supplies are disrupted.

This recommendation is particularly important for vulnerable populations who may struggle to access essential medicines during emergencies.

6. Affordable Insulin And Glucose Monitoring Must Become A Healthcare Priority

WHO has highlighted the need to make essential diabetes treatment more accessible and affordable.

According to the organisation, many people living with type 1 diabetes still struggle to obtain the insulin and monitoring equipment they need to survive.

The new guidelines support WHO’s global diabetes coverage target for 2030, which aims to ensure that all people with type 1 diabetes have access to affordable insulin treatment and blood glucose self-monitoring.

WHO is also encouraging countries to involve people living with type 1 diabetes in designing, implementing and evaluating diabetes programmes.

The objective is to make diabetes care more accessible, patient-centred and responsive to individual needs.

7. Early Diagnosis, Education And Long-Term Monitoring Are Equally Important

Insulin treatment alone is not enough to ensure effective diabetes management. Patients also need education, regular medical assessments and support to manage their condition throughout life.

People with type 1 diabetes must understand how to monitor their glucose levels, recognise symptoms of hypoglycaemia and hyperglycaemia, and respond appropriately when they become ill.

Diabetic ketoacidosis is another serious complication that requires particular attention.

It occurs when the body does not have enough insulin to use glucose effectively and starts breaking down fat for energy, producing acids called ketones. If untreated, this can become life-threatening.

Patients should receive appropriate guidance on glucose and ketone monitoring, sick-day management and when to seek emergency medical attention.

Regular follow-ups also help healthcare professionals assess treatment effectiveness and identify potential complications affecting the eyes, kidneys, nerves and cardiovascular system.

Can Adults Develop Type 1 Diabetes Later In Life?

Yes. Type 1 diabetes can develop at any age, including adulthood.

Although it is commonly diagnosed in children and adolescents, adults can also develop the condition. In some cases, symptoms appear gradually, which may delay diagnosis.

Common warning signs include:

  • Increased thirst.
  • Frequent urination.
  • Unexplained weight loss.
  • Persistent fatigue.
  • Increased hunger.
  • Blurred vision.
  • Unusual weakness.

Some people may also develop diabetic ketoacidosis, which can cause nausea, vomiting, abdominal pain, rapid or deep breathing and confusion.

Severe symptoms require immediate medical attention.

Adults who develop type 1 diabetes may initially be mistaken for having type 2 diabetes, particularly if they are diagnosed later in life. Appropriate clinical evaluation and laboratory investigations are important to establish the correct diagnosis.

Type 1 Diabetes Vs Type 2 Diabetes: What Is The Difference?

Although both conditions involve elevated blood glucose levels, their underlying causes and treatment requirements are different.

FeatureType 1 diabetesType 2 diabetes
Main causeAutoimmune destruction of insulin-producing beta cellsInsulin resistance and progressive impairment of insulin production
Insulin productionLittle or no insulinInsulin is initially produced, but the body does not use it effectively
Typical age of onsetCan occur at any age, often in childhood or adolescenceMore common in adults, but increasingly seen in younger people
TreatmentLifelong insulin therapy is essentialLifestyle changes, medicines and sometimes insulin
PreventionCurrently no established general prevention strategyRisk can often be reduced through lifestyle and risk-factor management

It is important to remember that type 1 diabetes is not caused by eating too much sugar or leading an unhealthy lifestyle. It is an autoimmune condition that requires lifelong medical management.

What Should People Living With Type 1 Diabetes Do Now?

WHO’s new guidelines reinforce the importance of consistent treatment and access to essential diabetes care.

Patients should:

  • Never stop or change insulin treatment without medical advice.
  • Monitor blood glucose regularly using an appropriate method.
  • Discuss whether continuous glucose monitoring is suitable and accessible.
  • Learn how to recognise and manage low blood glucose.
  • Keep emergency supplies and follow a doctor-approved sick-day plan.
  • Attend regular medical appointments to assess glucose control and screen for complications.
  • Discuss access to affordable insulin and monitoring supplies with their healthcare provider.

WHO’s first guidelines for adults with type 1 diabetes mark an important step towards improving access to essential treatment and standardising diabetes care across different healthcare settings. By emphasising insulin therapy, regular glucose monitoring, affordability and continuity of care, the recommendations aim to make lifelong diabetes management safer and more accessible. For patients, the message is clear: consistent insulin treatment, regular monitoring and informed medical support remain essential.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Do not change insulin doses or treatment regimens without consulting your healthcare professional.

Share
Written by
Satata Karmakar

Satata Karmakar is a health journalist and Editor of HealthWireMedia.com, with over 12 years of experience in journalism, investigative reporting, newsroom editing and healthcare news.As Editor of HealthWire Media, Satata focuses on delivering accurate, evidence-based and accessible health journalism that helps readers make sense of complex medical and healthcare developments. She specialises in translating medical research, clinical findings, public-health updates and healthcare regulations into clear, engaging stories for healthcare professionals and the wider public.Her areas of coverage include public health, medical research, disease prevention, healthcare policy, health technology, medical education and regulatory developments. She places particular emphasis on verifying health claims through peer-reviewed research, official government notifications, expert interviews and credible institutional sources, including the National Medical Commission (NMC).She is committed to responsible health reporting that prioritises accuracy, context and transparency—especially when covering emerging research, medical breakthroughs, health risks and treatment-related information. Her editorial approach aims to make reliable health information understandable without oversimplifying science or overstating medical claims.Through her work, she seeks to strengthen public understanding of healthcare issues and contribute to informed conversations around health, medicine and policy.Outside the newsroom, Satata enjoys reading and painting, pursuits that continue to inspire her curiosity, creativity and storytelling.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Latest News

Government Seizes 18,000 Liters of Fake Edible Oil in Rajasthan

The Food Safety and Standards Authority of India (FSSAI) recently reported that the government has detained 18,000 liters of fake cooking oil in...

Latest News

Fire at Eye Hospital in Delhi’s Lajpat Nagar, 12 Fire Trucks on Scene

A fire broke out at an eye hospital in Delhi’s Lajpat Nagar area on Wednesday morning (June 5). According to the Delhi Fire...

Latest News

World No Tobacco Day 2024: Expert Shares How Tobacco Is Harming You

The theme of World No-Tobacco Day 2024 is, “PROTECTING CHILDREN FROM TOBACCO INDUSTRY INTERFERENCE.’ Youth protection is the main focus this year. As...

Latest News

No Tobacco Day: How To Quit Smoking Without Taking Any Medicines?

World No Tobacco Day: Your Guide to Quit Smoking without any Medicines!

Cholesterol Levels
Latest News

7 Easy Tips To Lower Cholesterol Levels Naturally

7 Handy Health Tips to Tame Your Cholesterol Levels Naturally.

Section title